KUALA LUMPUR (Dec 23): Dataprep Holdings Bhd’s subsidiary has been appointed as the project delivery partner for the outsourcing of integrated solutions for Covid-19 rapid molecular testing.
In a bourse filing on Thursday (Dec 23), Dataprep said its subsidiary Dataprep Asia Sdn Bhd had received the letter of consent from the Ministry of Health to commence the trial run of Covid-19 screening RT-PCR testing under the MiCo BioMed brand.
It said testing will be conducted specifically at the country's main international entry points, such as the Kuala Lumpur International Airport (KLIA), klia2, the Langkawi International Airport, the Senai International Airport and Tambak Johor (the Johor-Singapore Causeway).
Dataprep said the deployment of testing is expected to contribute positively to its earnings for the financial year ending Dec 31, 2022 and onwards.
At the midday break on Thursday, Dataprep had shed 1.5 sen to 84 sen, valuing it at RM563.19 million.